Organicell Regenerative Medicine, Inc. (CIK: 0001557376) EDGAR, Information, Filings... CompaniesBIO.Com

Organicell Regenerative Medicine, Inc.

Mailing address
4045 SHERIDAN AVENUE, SUITE 239, MIAMI, Nevada, 33140
Phone
888-963-7881
State location
Florida
State of incorporation
Nevada
Fiscal year end
October 31
SIC
3790 - (CF Office: Office of Manufacturing) MISCELLANEOUS TRANSPORTATION EQUIPMENT
Filings
N/A

Organicell Regenerative Medicine, Inc. (CIK: 0001557376) is an American company incorporated in the state of Florida. Head office is located at 4045 SHERIDAN AVENUE, SUITE 239, MIAMI, Florida, 33140. Work in the industry 3790 - (CF Office: Office of Manufacturing) MISCELLANEOUS TRANSPORTATION EQUIPMENT. Organicell Regenerative Medicine, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Biotech Products Services & Research, Inc. from 2015-17-Sep to 2018-15-Jun
BESPOKE TRICYCLES INC from 2012-04-Sep to 2015-14-Sep

Owner	Filings	Transaction Date	Type of Owner
Skycrest Holdings, LLC	0001952164	Jun-26-2023	10 percent owner
Leider Harry L.	0001888273	Jun-06-2023	director, officer: CEO and Director
Golub Howard Lawrence	0001978938	Jun-06-2023	officer: Executive Vice President & CSO
CHISTE JOHN F	0001217918	Sep-23-2022	director
GLAUSER STEVEN JERRY	0001385272	Sep-23-2022	director
Singh Gurvinder Pal	0001944625	Sep-23-2022	director
Modi Bhupendra Kumar	0001945023	Sep-23-2022	director
Bretz Charles Luther	0001947541	Sep-23-2022	director
Stearn Leathem S	0001950011	Sep-23-2022	director
Likes Ryan C	0001946828	Sep-13-2022	officer: Chief Operating Officer
Grey Wendy	0001946695	Aug-19-2022	10 percent owner
Greyt Ventures, LLC	0001946700	Aug-19-2022	10 percent owner
Sinnreich Matthew Phillip	0001939708	Jul-21-2022	officer: COO and Acting CEO
Meglin Allen James	0001815113	Mar-31-2020	director
Carbonara Michael	0001825157	Mar-31-2020	director
Shapiro George Craig	0001804141	Oct-31-2019	director, officer: Chief Medical Officer
Zucker Robert W	0001744846	May-29-2018	director
MANAGEMENT & BUSINESS ASSOCIATES INC	0001308769	Apr-23-2018	10 percent owner
MITRANI MARIA INES	0001690319	Apr-23-2018	officer: Chief Science Officer
Iglesias Manuel E.	0001745332	Apr-23-2018	director, officer: Director and CEO
BOTHWELL IAN T	0001207638	Apr-06-2018	10 percent owner, officer: Chief Financial Officer
TADDEO PETER	0001703129	Mar-08-2017	director
SUDDARTH TERRELL	0001703272	Mar-08-2017	director, officer: Chief Technology Officer
Werber Bruce	0001690348	Nov-04-2016	director, 10 percent owner, officer: Chief Operating Officer
Mitrani Albert	0001644416	May-29-2015	director, officer: Chief Executive Officer
GOODHEW JOHN	0001583177	Jul-25-2013	director, 10 percent owner, officer: CEO, CFO, President, Secretary

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Organicell Regenerative Medicine, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001829126-25-005526 (34 Act) Size: KB	Jul-29-2025	000-55008 251161826
8-K	Document	Current report filing Acc-no: 0001829126-25-005232 (34 Act) Size: KB	Jul-21-2025	000-55008 251137307
8-K	Document	Current report filing Acc-no: 0001829126-25-004961 (34 Act) Size: KB	Jul-09-2025	000-55008 251112349
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001829126-25-004768 ( Act) Size: 0 KB	Jun-27-2025
8-K	Document	Current report filing Acc-no: 0001829126-25-004668 (34 Act) Size: KB	Jun-24-2025	000-55008 251066799
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001829126-25-004665 ( Act) Size: 0 KB	Jun-24-2025
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001829126-25-004512 (34 Act) Size: KB	Jun-16-2025	000-55008 251050260
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001829126-25-004494 ( Act) Size: 0 KB	Jun-13-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001829126-25-004421 ( Act) Size: 0 KB	Jun-12-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001829126-25-004348 ( Act) Size: 0 KB	Jun-09-2025
SCHEDULE 13D/A	Document	Acc-no: 0001829126-25-003936 (34 Act) Size: KB	May-23-2025	005-87575 25983735
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001829126-25-003927 ( Act) Size: 0 KB	May-23-2025
EFFECT	Document	Acc-no: 9999999995-25-001667 (33 Act) Size: KB	May-20-2025	333-286105 25970776
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001829126-25-003766 (33 Act) Size: KB	May-16-2025	333-286105 25959496
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001829126-25-003767 ( Act) Size: KB	May-16-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001829126-25-003765 ( Act) Size: 0 KB	May-16-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001829126-25-003582 ( Act) Size: 0 KB	May-12-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001829126-25-003575 ( Act) Size: 0 KB	May-12-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001829126-25-003574 ( Act) Size: 0 KB	May-12-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001829126-25-003573 ( Act) Size: 0 KB	May-12-2025

Recent 20 filings. View all Organicell Regenerative Medicine, Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Organicell Regenerative Medicine, Inc. overview
Organicell Regenerative Medicine, Inc. job
Organicell Regenerative Medicine, Inc. stock
Organicell Regenerative Medicine, Inc. ownership
Organicell Regenerative Medicine, Inc. CEO
Organicell Regenerative Medicine, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.